跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
HAVRIX 1440 Hepatitis A vaccine inactivated 1440 ELISA units/1mL injection syringe - TGA Drug Approval Details
Approvals
/
TGA
/
HAVRIX 1440 Hepatitis A vaccine inactivated 1440 ELISA units/1mL injection syringe
Approved
STANDARD
HAVRIX 1440 Hepatitis A vaccine inactivated 1440 ELISA units/1mL injection syringe
GlaxoSmithKline Australia Pty Ltd
🇦🇺 Therapeutic Goods Administration
Approval Date
May 30, 2025
Approval ID
47d112f57a2748c4
Company
GlaxoSmithKline Australia Pty Ltd
Type
Standard
Approval Details
Approval Id
47d112f57a2748c4
Product Name
HAVRIX 1440 Hepatitis A vaccine inactivated 1440 ELISA units/1mL injection syringe
Artg Id
147331
Artg Name
HAVRIX 1440 hepatitis A vaccine inactivated 1440 ELISA units/1mL injection syringe
Sponsor
GlaxoSmithKline Australia Pty Ltd
Company Detail Path
/organization/glaxosmithkline-australia-pty-ltd
Artg Date
2008-04-22
Registration Type
Medicine
Therapeutic Good Type
Medicine
Licence Status
A
Licence Category
RE
Consumer Medicine Info
https://medical-cdn.nocode.com/drug_tga/cee703d460e24c410fcd4e68f3b012db.pdf
Product Information
https://medical-cdn.nocode.com/drug_tga/8810039b278b80525f96e15b353f10b8.pdf
Active Ingredients
Approved
Quick Info
Agency
TGA
Country
🇦🇺
Approval Date
May 30, 2025
Approval ID
47d112f57a2748c4
Type
Standard
Back to TGA Approvals